ASX
Invex Therapeutics Ltd
IXC:ASX•Healthcare
Sensitive ASX Announcement
First UK Clinical Site Activated in IIH EVOLVE Phase 3 Trial
Published: 24/10/22, 09:21am (AEST)•3 pages